Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gastrointestinal mucosal protection comprises physical, chemical, and immune mechanisms that safeguard the lining of the GI tract from acid, digestive enzymes, toxic substances, and pathogens. Key components include the mucus gel layer (primarily formed by mucins like MUC1, MUC5, and MUC6), epithelial cells that secrete bicarbonate to neutralize acid, a robust local blood flow for oxygenation and pH regulation, and various immune factors and cytokines. Disruption of these defense processes—by drugs (e.g., NSAIDs, alcohol), pathogens (e.g., *Helicobacter pylori*), or stress—can lead to erosive and ulcerative disease, bleeding, and infection
For protective agents: Prostaglandin analogs (stimulate mucus and bicarbonate production, decrease acid secretion); Sucralfate forms a protective barrier over mucosal injuries; Bismuth subsalicylate coats ulcers and has antimicrobial effects. For damaging agents: NSAIDs block prostaglandin synthesis, reducing mucus/bicarbonate production; Alcohol damages mucus layer
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal mucosal protection.